Answers are grounded in this paper and cite their sources.
The overall strategy for the synthesis of penta-up to octa-saccharides, representing the biological repeating unit of the Shigella flexneri serogroup Y lipopolysaccharide, is described. The key intermediate, the common terminal trisaccharide, α-L-Rhap-(1 → 2)-α-L-Rhap(1 → 3)-α-L-Rhap, has been synthesised by a series of Königs–Knorr reactions. A selectively protected rhamnose intermediate has been developed for the synthesis of this trisaccharide as its allyl glycoside. Allyl α-L-rhamnopyranoside was converted into the corresponding 2-O-benzoyl-4-O-benzyl derivative via a 2,3-orthobenzoate. Königs–Knorr reaction between this partially blocked rhamnoside and 2-O-acetyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl chloride afforded the blocked disaccharide. Selective transesterification of the 2′-Oacetyl group in the presence of the 2-O-benzoate yielded the disaccharide, selectively deblocked at the C-2′ position. Reaction with the same rhamnopyranosyl chloride gave the fully blocked trisaccharide. Deallylation, followed by treatment with NN-dimethyl(chloromethylene)ammonium chloride, then gave the corresponding trisaccharide chloride. In conjunction with the disaccharide methyl 2-O-(2′acetamido-4′,6′-O-benzylidene-2′-deoxy-β-D-glucopyranosyl)-3,4-di-O-benzyl-α-L-rhamnopyranoside, the synthesis of the blocked pentasaccharide was accomplished. Transesterification, followed by hydrogenolysis in aqueous acetic acid, afforded the pure pentasaccharide hapten, α-L-Rhap-(1 → 2)α-L-Rhap-(1 → 3)-α-L-Rhap-(1 → 3)-β-D-GlcpNAc-(1 → 2)-α-L-Rhap, as its methyl glycoside, for use in binding studies and n.m.r. studies.
No takes yet. Share an insight, caveat, or question.
Pinto et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: